Provided by Tiger Trade Technology Pte. Ltd.

Liminatus Pharma LLC

0.1422
-0.0090-5.95%
Post-market: 0.1401-0.0021-1.48%19:58 EDT
Volume:2.80M
Turnover:403.72K
Market Cap:6.38M
PE:-0.37
High:0.1548
Open:0.1512
Low:0.1359
Close:0.1512
52wk High:33.66
52wk Low:0.1320
Shares:44.88M
Float Shares:9.56M
Volume Ratio:0.42
T/O Rate:29.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3877
EPS(LYR):-0.4300
ROE:--
ROA:-62.65%
PB:-48.13
PE(LYR):-0.33

Loading ...

Company Profile

Company Name:
Liminatus Pharma LLC
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
1
Office Location:
12611 Hiddencreek Way,Unit C,Cerritos,California,United States
Website:
- -
Zip Code:
90703
Fax:
- -
Introduction:
Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC.

Directors

Name
Position
Chris Kim
Chief Executive Officer and Director
Eun Sook Lee
Independent Director
Ji Yeon Baek
Independent Director
Nicholas Fernandez
Independent Director
Philip Lemons
Independent Director
Richard Baek
Independent Director

Shareholders

Name
Position
Chris Kim
Chief Executive Officer and Director
Scott Dam
Chief Financial Officer
Beom K. Choi
Chief Technology Officer
Byong Chul Yoo
Chief Science Officer
Sang jin Daniel Lee
Head of Research & Development